Table 2

Incremental QALYs, costs and ICERs for scenarios 1 and 2, UK and USA

Serum spectroscopy test cost (£)Scenario 1—primary careScenario 2—secondary care
∆QALY∆CostICERΔQALY∆CostICER
UK
 508.81−422 116−47 913
(dominates)
52.86527 6469982
 1008.8177 884884052.861 027 64619 441
USA
 1008.81−1 718 475−195 058 (dominates)52.86536 70210 153
 2008.81−218 475−24 798
(dominates)
52.862 036 70238 530
  • ∆QALY, ∆Cost: difference is QALYs/costs (with serum spectroscopy test—without test), 10 000 patients.

  • ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.